Chitosan and Its Structural Modifications for siRNA Delivery
Advanced Pharmaceutical Bulletin · 19.03.2023 · 13 (2) · 275-282
DOI: 10.34172/apb.2023.030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 08.01.2022. Verfasst von Mona Y Al-Absi und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, United Kingdom. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The use of RNA interference mechanism and small interfering RNA (siRNA) in cancer gene therapy is a very promising approach. However, the success of gene silencing is underpinned by the efficient delivery of intact siRNA into the targeted cell. Nowadays, chitosan is one of the most widely studied non-viral vectors for siRNA delivery, since it is a biodegradable, biocompatible and positively charged polymer able to bind to the negatively charged siRNA forming nanoparticles (NPs) that will act as siRNA delivery system. However, chitosan shows several limitations such as low transfection efficiency and low solubility at physiological pH. Therefore, a variety of chemical and non-chemical structural modifications of chitosan were investigated in the attempt to develop a chitosan derivative showing the features of an ideal siRNA carrier. In this review, the most recently proposed chemical modifications of chitosan are outlined. The type of modification, chemical structure, physicochemical properties, siRNA binding affinity and complexation efficiency of the modified chitosan are discussed. Moreover, the resulting NPs characteristics, cellular uptake, serum stability, cytotoxicity and gene transfection efficiency in vitro and/or in vivo are described and compared to the unmodified chitosan. Finally, a critical analysis of a selection of modifications is included, highlighting the most promising ones for this purpose in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, United Kingdom.
ORCID-Profile: Mona Y Al-Absi, Anna Eleonora Caprifico, Gianpiero Calabrese
Zitieren
APA
Al-Absi, M. Y., Caprifico, A. E., & Calabrese, G. (2023). Chitosan and Its Structural Modifications for siRNA Delivery. Advanced Pharmaceutical Bulletin, 13(2), 275-282. https://doi.org/10.34172/apb.2023.030
Vancouver
Al-Absi MY, Caprifico AE, Calabrese G. Chitosan and Its Structural Modifications for siRNA Delivery. Advanced Pharmaceutical Bulletin. 2023;13(2):275-282. doi:10.34172/apb.2023.030
BibTeX
@article{AlAbsi2023,
author = {Al-Absi, Mona Y and Caprifico, Anna Eleonora and Calabrese, Gianpiero},
title = {Chitosan and Its Structural Modifications for siRNA Delivery},
journal = {Advanced Pharmaceutical Bulletin},
year = {2023},
volume = {13},
number = {2},
pages = {275--282},
doi = {10.34172/apb.2023.030}
}
EUVIMED